The Liver Meeting® 2017, the Annual Meeting of the American Association for the Study of Liver Disease
Oct 23, 2017
Subcutaneous delivery of a RNA interference (RNAi) therapeutic candidate for alpha-1 antitrypsin deficiency (AATD)-related liver disease produces deep and prolonged knockdown of plasma AAT
- Publication Number: LB-21
- Session: Late-Breaking Poster Session
- Session Date and Time: October 23, 2017 from 8:00 AM to 5:30 PM
· Authors: Christine I. Wooddell, et al.